DESIGN OF A NEW MULTIPLE-UNIT CONTROLLED-RELEASE FORMULATION OF METOPROLOL - METOPROLOL CR

被引:80
作者
SANDBERG, A
RAGNARSSON, G
JONSSON, UE
SJOGREN, J
机构
关键词
D O I
10.1007/BF00578405
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S3 / S7
页数:5
相关论文
共 13 条
[1]  
ASPLUND J, 1981, ANN CLIN RES, V13, P30
[2]   INVESTIGATION OF DRUG ABSORPTION FROM THE GASTROINTESTINAL-TRACT OF MAN .3. METOPROLOL IN THE COLON [J].
GODBILLON, J ;
EVARD, D ;
VIDON, N ;
DUVAL, M ;
SCHOELLER, JP ;
BERNIER, JJ ;
HIRTZ, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 :S113-S118
[3]   EFFECTS ON EXERCISE TACHYCARDIA DURING 48 HOURS OF A SERIES OF DOSES OF ATENOLOL, SOTALOL, AND METOPROLOL [J].
HARRON, DWG ;
BALNAVE, K ;
KINNEY, CD ;
WILSON, R ;
RUSSELL, CJ ;
SHANKS, RG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (03) :295-302
[4]  
JOHNSSON G, 1975, ACTA PHARMACOL TOX, V36, P31
[5]  
JONSSON UE, 1983, 2ND INT C DRUG ABS E, P68
[6]   FOOD-INDUCED CHANGES IN THEOPHYLLINE ABSORPTION FROM CONTROLLED-RELEASE FORMULATIONS .1. SUBSTANTIAL INCREASED AND DECREASED ABSORPTION WITH UNIPHYL TABLETS AND THEO-DUR SPRINKLE [J].
KARIM, A ;
BURNS, T ;
WEARLEY, L ;
STREICHER, J ;
PALMER, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (01) :77-83
[7]  
LANGENBUCHER F, 1982, PHARM IND, V44, P1166
[8]  
MCLEAN AJ, 1978, CLIN PHARMACOL THER, V24, P5
[9]  
MELANDER A, 1977, CLIN PHARMACOL THER, V22, P108
[10]  
SANDBERG A, 1986, ACTA PHARMACOL TOX, V59, P85